You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Colorectal cancer

Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy

  • Technology appraisal guidance
  • Reference number: TA307
  • Published:  25 March 2014
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Colorectal cancer (metastatic) - aflibercept: equality impact assessment form - guidance development

Colorectal cancer (metastatic) - aflibercept: equality impact assessment form - guidance development Colorectal cancer (metastatic) - aflibercept: equality impact assessment form - guidance development
26 September 2014
(22.42 Kb 6 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 26 September 2014

Back to top